fabI inhibitors (Aurigene)

N/A

Report date: 2025/06/11 10:24:54
NME

Base Information

Drug NamefabI inhibitors (Aurigene)
Drug Alias NameMDR strains (Aurigene)small molecule therapeutic for infection(Aurigene)AU-PEA11AU-170-2014AU-TEA5
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionEnoyl-acyl-carrier protein reductase inhibitors
TargetsEnoyl-acyl-carrier protein reductase
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurigene Oncology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAurigene Oncology Ltd
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A